Infection by herpesviruses can result in profound immunosuppressive or immunomodulatory effects. However, no significant information is available on the effect of such infections on the production of immunoregulatory cytokines. We studied the kinetics of production of two monocyte-derived cytokines, interleukin 6 (IL-6) and tumor necrosis factor-a (TNFa), induced by Epstein-Barr virus (EBV) and herpes simplex virus type 1 (HSV-1) in peripheral blood mononuclear cell cultures and in fractionated cell populations. We observed that, when compared to HSV-1, EBV is a stronger inducer of IL-6. In EBV-infected cultures, IL-6 protein was detected at day 1 postinfection and gradually increased with time. In contrast, lower amounts of IL-6 were detected 5 d postinfection in HSV-1-infected cultures. HSV-1-infected cultures secreted significant amounts of TNFa protein after 5 d of culture and reached a maximal level of production at day 7, whereas EBV inhibited TNFa production. In fractionated cell populations, monocytic cells were found to be the main source of IL-6 synthesis after EBV or HSV-1 infection. However, TNFa synthesis in HSV-1-infected cultures was from both B and monocytic cells. By using the polymerase chain reaction technique we show that, after infection by these two herpesviruses, differences in cytokine gene products are also observed at the transcriptional level. These observations demonstrate that EBV and HSV-1 exert differential effects on IL-6 and TNFa gene transcription and on the resulting protein secretion in human mononuclear blood
Introduction
Herpesviruses are ubiquitous and highly pathogenic and can produce acute, chronic, latent, or recurring infections in their natural hosts. Epstein-Barr virus (EBV) is known to infect and transform human B lymphocytes in vitro. Herpes simplex virus type 1 (HSV-1)' also interacts intimately with the immune system by infecting lymphoid cells. Viral reactivation is common to both these viruses and can result in severe infections, especially in immunodeficient hosts (1, 2) .
The immune system plays a key role in the control/surveillance of virus-infected cells. In this regard, T cell-derived cytokines such as interleukin 2 (IL-2) (3) (4) (5) and interferon-y (IFNy) (3, 4, 6) are well known for their cellular regulatory roles in host defense mechanisms. Furthermore, interleukin 6 (IL-6) and tumor necrosis factor-a (TNFa), which are produced mainly by monocytic cells (7) (8) (9) , are known to act on a variety of target cells. For example, IL-6 is involved in the induction of B cell differentiation, induction of IL-2 and IL-2 receptor expression, and in induction of proliferation and differentiation ofT cells (for review, see reference 10). TNFa also exerts diverse physiological functions such as increasing macrophage cytotoxicity (1 1, 12), mediation of natural cellular cytotoxicity (13) and playing regulatory roles in T and B cell activation and maturation (14, 15) . In the HSV-1 system, little is known about the regulatory roles played by cytokines. Previous reports suggest that exogenous IL-2 and IFNy protected neonatal mice from a lethal HSV infection (16, 17) . Furthermore, it has been shown that EBV-infected human peripheral blood mononuclear cells (PBMC) can produce IL-2 and IFNy (18) and that these cytokines play a crucial role in the resistance of EBV infection (19, 20) . However, in both systems, little is known about the role ofIL-6 and TNFa in the immunosurveillance of infected cells.
We have shown in a previous report that EBV can interact with monocytic cell function by reducing the levels of TNFa transcription and protein synthesis (21) . To learn more about the key role played by the monocytic cells and the monokines they secrete during viral infections, we compared the effects of two herpesviruses, EBV and HSV-1, on the transcription and release of IL-6 and TNFa by PBMC. We observed that EBV is a better inducer of IL-6 than HSV-1. In contradistinction to EBV, HSV-I was revealed to be an inducer of TNFa activity. The different monokine RNA levels detected in virus-infected cells using polymerase chain reaction (PCR) suggest that EBV and HSV-l can exert their effects at the transcriptional level.
Methods
Cellpreparations. PBMC from EBV and HSV-1 antibody-negative (seronegative) and antibody-positive (seropositive) healthy donors were 1. Abbreviations used in this paper: EBNA, Epstein-Barr virus nuclear antigen; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; HSV-1, herpes simplex virus type 1; PCR, polymerase chain reaction; TNFa, tumor necrosis factor-a. obtained by centrifugation of heparinized blood over Ficoll-Hypaque gradients (Pharmacia, Uppsala, Sweden). The EBV-seropositive or-seronegative status of these donors was defined by the presence or absence, respectively, of antibodies to EBV capsid antigen and to EBV nuclear antigen (EBNA) by using immunofluorescence assays as described earlier (22, 23). Seropositivity for HSV-1 was confirmed by standard complement fixation test. Fractionated/enriched cell populations were obtained by incubating PBMC at least once with known specific antibodies and rabbit complement as described (24). Antibodies used were anti-human T cells (OKT3, OKTl 1), anti-human B cells (OKB7), and anti-human monocytes (OKM 1, OKM 14) (Ortho Diagnostic Systems, Raritan, NJ). The purity of fractionated mononuclear cell populations used was evaluated by flow cytometry after an immunofluorescence test using specific antibodies described above and was as follows: 94-97% for T cells, 87-93% for B cells, and 88-92% for monocytes.
Viruses and mitogen stimulation. The procedures followed for preparation and titration of cell-free EBV (strain B95-8) and HSV-I (strain McIntyre) were as described previously (22-23, [25] [26] [27] . Briefly, fractionated mononuclear cells and PBMC (1 x 106 cells) were infected with 200 Ml of EBV preparation with a titer of 2 x 105 EBNA-inducing U/ml or with HSV-l preparation at a multiplicity of infection of 50 plaque-forming units (PFU) per cell. After 1 h of incubation at 370C, 5% CO2 in air, and humid atmosphere, 0.8 ml of culture medium was added and resuspended cells were incubated. Viral preparations and culture medium tested for the presence of endotoxin by the limulus amebocyte assay (Sigma Chemical Co., St. Louis, MO) were found to contain < 20 pg/ml of contaminating endotoxin. The viral preparations used contained undetectable levels ofIL-I, IL-2, IL-3, IL-4, IL-6, IL-8, and TNF, as evaluated by using enzyme-linked immunosorbent assay (ELISA; see below). PBMC (1 X 106 cells) stimulated with lipopolysaccharides (LPS) (1.0 ug/ml) were used as positive control. Cell cultures (1 X 106 cells/ml) treated with EBV, HSV-1, and LPS were grown in RPMI-1640 medium supplemented with 10% heat-inactivated fetal bovine serum, 50 U/ml penicillin, 50 jg/ml streptomycin, 30 ,g/ml gentamycin, and 10 mM Hepes buffer. Cell-free supernatants from each infected and uninfected PBMC cultures were collected on different days ofculture (days 1, 3, 5, and 7) and stored at -70'C until used for cytokine determinations.
Assay for cytokine activities. Supernatants of virus-infected and LPS-treated cultures as well as those of uninfected control cultures were collected on different days for measurement of IL-6 and TNFa activities. Cytokines were quantitated using ELISA kits, according to the manufacturer's technical guidelines (R & D Systems, Inc., Minneapolis, MN).
Cytokine mRNA analysis. Cells were lysed at 8 h posttreatment and total RNA was isolated using a modified guanidium isothiocyanate procedure (28). Cytokine mRNA levels were analyzed by using a reverse transcriptase-PCR procedure as described (29) . PCR products were analyzed on a 6.0% denaturing PAGE and autoradiographed overnight at -70°C using Cronex film (DuPont Co., Wilmington, DE). The following primers were used: TNFa primer A located at 2199-2175 (5'-CCCTCAAGCTGAGGGGCAGCTCCAG-3') and primer B located at 2826-2801 (5'-GGGCAATGATCCCAAAGTAGACCTG-3') of the fourth TNFa exon; IL-6 primer A located at 4144-4124 (5'-CAAAGAATCTAGATGCAATAA-3) and IL-6 primer B located at 4320-4299 (5'-GCCCATTAACAACAACAATCTG-3) in the IL-6 cDNA. The glyceraldehyde 3-phosphate dehydrogenase (GAPDH) product was amplified using primer A (5'-GGTACCTCTTCC-GACCCC-3') located at 389-372 and primer B (5-GTTTCAACAG-TACCTACTGG-3') located at 566-547 derived from a full-length GAPDH cDNA (30) . The intensity of the PCR products was determined by laser densitometry. For each sample the amount of TNFa and IL-6 mRNAs was quantitated relatively to their respective level of GAPDH mRNA. The given ration was compared to the one obtained (i.e., the internal basal mRNA control) (30) in unstimulated cells using the following formula: (OD of cytokine mRNA transcripts ofthe sample/OD ofGAPDH transcripts ofthe sample)/(OD ofcytokine mRNA transcripts ofunstimulated cells/OD ofGAPDH mRNA transcripts of unstimulated cells.) = relative mRNA level. Constant amplification in reaction tubes was assessed by coamplifying exogenous DNA (SV2CAT) in some samples. Furthermore, all reactions were carried out in conditions previously described (29) in which amplification was linear.
Results
To determine the cytokine inducing potential of both HSV-l and EBV, PBMC from seronegative and seropositive donors were infected in parallel with each virus and their culture supernatants were assayed on different days postinfection for IL-6 and TNFa activities. It was thus found that 50 PFU/cell of HSV-1 and 2 X I05 EBNA-inducing U/ml of EBV represent optimal doses for cytokine inductions (Table I) .
IL-6 synthesis by PBMC. The results given in Fig. 1 indicate that EBV induces IL-6 protein synthesis. Production of IL-6 was readily detected in PBMC cultures from seropositive donors, 24 h after EBV infection. IL-6 synthesis increased steadily and reached a maximal level 7 d postinfection. In contradistinction to EBV, HSV-1 did not induce significant levels of IL-6 protein before day 5 postinfection, in that the amounts of IL-6 detected during this period were below the background level. Comparable results were obtained with PBMC from seronegative donors (Fig. 2) . In fact, IL-6 production was detected at day 3 postinfection and reached a maximal level by day 7. In HSV-I -infected PBMC cultures, IL-6 synthesis was detected at day 3 but decreased after 7 d postinfection. However, even if IL-6 and TNFa production patterns were similar, a higher level of protein was detected in PBMC cultures from seropositive donors than in PBMC culture from seronegative donors. TNFa synthesis by PBMC. During the first 3 d postinfection, the amounts of TNFa protein detected in culture supernatants of EBV-infected as well as of HSV-l-infected PBMC from seropositive donors were not higher than the level ofspontaneous release by unstimulated cells (Fig. 3) . However, in HSV-l-infected cultures, TNFa production was found increased at day 5 postinfection and reached a maximal level after 7 d ofculture. In supernatants from EBV-infected PBMC cultures, the amounts ofTNFa detected at different times postinfection were always less than in those from unstimulated cultures, regardless of the viral antibody status of the donor, suggesting that EBV suppressed TNFa protein secretion (Fig. 4) .
Cytokine production byfractionated cell populations. In an attempt to determine whether monocytic cells are directly stimulated by these viruses to produce cytokines or if another cell population is involved in such a cytokine synthesis, we performed the same sets of experiments, as above, using fractionated cell populations. As shown in Table II These data represent mean of three separate experiments±SD. Viral preparations pretreated with neutralizing antibodies were unable to induce cytokine DAYS OF CULTURE production.
populations. These results suggest that both viruses can directly act on monocytic cells to induce IL-6 production. On the other hand, TNFa was also produced by other than monocytic cells after HSV-l infection. In fact, TNFa protein levels in culture supernatants of enriched B cells were comparable to those of monocytic cell populations (Table III) . No TNFa protein was detected in EBV-treated, fractionated cell populations. Effects ofinactivated viruses on cytokine production. To determine the role of inactivated virus particles in cytokine induction, additional experiments were performed. EBV and HSV-I preparations were inactivated by treatment with ultraviolet light (UV) before their use in the infection procedure; culture supernatants were harvested at different times posttreatment and assayed for the presence of IL-6 and TNFa (Table  IV) . The results obtained show that UV irradiation of EBV did not affect the IL-6-inducing ability of the virus particle, suggesting a role for a viral structural (envelope) protein in this IL-6 induction. On the other hand, IL-6 protein levels were increased by the use of UV-irradiated HSV-1. This suggests that infectious HSV-I might suppress IL-6 synthesis. However, UV irradiation of HSV-I did not affect the TNFa protein release suggesting that HSV-l infectivity/replication is not required for TNFa induction. This contrast with EBV-treated cultures, where the TNFa protein levels were not affected by the use of UV-irradiated particles whereas infectious EBV had a down-regulatory effect on this cytokine's synthesis.
Analysis of mRNAs for IL-6 and TNFa. To extend our study at the molecular level, we evaluated the effects of viral infection on cytokine gene expression using the PCR technique. The steady-state levels of IL-6 and TNFa mRNA were examined in unstimulated, LPS-, EBV-, and HSV-1-infected PBMC at 8 h posttreatment. As shown in Fig. 5 (left), after amplification (201 basepair fragment), IL-6 transcripts were detected in LPS-treated cells (lane 2), as well as in EBV-(lane 3) or HSV-l-infected cells (lane 4). In the same total RNA extracts, TNFa transcripts (Fig. 5, right) were also detected (lanes 3, 4, and 5, respectively). Total length of the amplified sequence from the fourth TNFa exon is a 412 basepair fragment. To quantitate the IL-6 and TNFa mRNA levels induced in infected PBMC, the autoradiographs were examined by laser densitometry and the fold increase in cytokine's mRNA in each sample was calculated relative to the basal levels of GAPDH RNA in the sample. As shown in Fig. 6 , IL-6 transcripts were weakly induced in HSV-l-treated PBMC com-1852 Gosselin et al. x 105 EBNA-inducing U/ml as described above (see Table I ). ND, Heat-inactivated HSV-1
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Culture supernatants were harvested at day 5 posttreatment and assayed for cytokine activities. Virus inactivation was carried out using heat (56°C/60 min) or UV irradiation (265 nm/60 min) and was confirmed by the fact that heat-or UV-treated virus preparations (in contrast to untreated control virus samples) were unable to infect susceptible targets (i.e., BJA-B cells for EBV and Vero cells for HSV- 
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(31, 32), suggesting that IL-6 might indeed be used as a paracrine/autocrine growth factor by these cells (33). Another recent study indicated that expression ofan exogenous IL-6 gene in EBV-transformed B cells confers growth advantage and in vivo tumorigenicity (34) . The increased amounts of IL-6 protein that we have measured in the culture supernatants ofEBVinfected PBMC support these observations. Interestingly, HSV-1 appears to have a weak IL-6 inducing ability which is detectable only 5 d postinfection. Our results also suggest that IL-6 production is delayed in cell cultures treated with infectious HSV-1 compared with inactivated virus.
The fact that the production of TNFa was different in PBMC cultures infected by each virus is also very interesting. In EBV-infected PBMC cultures, the detectable level of TNFa protein was below that of uninfected cultures (controls), even when examined 7 d postinfection. TNFa is known to have antiviral activity against certain DNA and RNA viruses (35, 36) . Moreover, recombinant TNFa has been shown to inhibit the proliferation of EBV-transformed B cells (37) . It is therefore possible that EBV acquired the ability to shut down TNFa synthesis and thus avoid this cytokine's inhibitory effect, as we have already suggested (21) . On the other hand, in HSV-1-infected PBMC cultures, TNFa production started at day 5 postinfection and increased significantly by day 7. As observed in the case ofHSV-I -induced IL-6 production, no TNFa synthesis was detected in cell culture supernatants within 3 d after HSV-l infection. A previous report showed that exogenous TNFa by itself has no inhibitory effects on HSV-1 replication (38) . The presence of TNFa protein detected after 5 d of culture indicates that HSV-l may be insensitive to the antiviral effect of TNFa.
The experiments performed with fractionated cell populations indicate that both viruses directly interact with monocytes/macrophages to induce IL-6 synthesis, and no other cell populations are required for such induction. In fact, larger amounts of IL-6 protein were detected in culture supernatants ofenriched monocytic cell populations. This is in contrast with TNFa, where comparable levels ofthis protein were measured in enriched B and monocytic cell populations after infection with HSV-1. The observation that no TNFa protein was detected in EBV-infected cell cultures suggests that EBV is a strong inhibitor of this cytokine.
Our results showing that UV-irradiated (and not heat-inactivated) EBV and TNFa, respectively, and that virus infectivity is not essential for this process. The fact that the counterpart heat-inactivated viral preparations had no effect on the synthesis of these cytokines would suggest that the heat treatment had a denaturing effect on viral attachment molecules likely rendering them ineffective as ligands to transduce the required signal(s). In any event, further research is needed to delineate the precise molecular events in this process.
The present results clearly illustrate the differential effects of EBV and HSV-l infections on the immune system, specifically in regards to production of monocyte-derived cytokines. The stronger IL-6 production detected in EBV-infected PBMC cultures infer that this cytokine may be used as a growth factor by EBV-infected cells. On the other hand, HSV-l could be insensitive to the effect of TNFa as judged by the presence of this cytokine in HSV-l-infected cultures. This is in contrast to the effect of TNFa on EBV (37) .
Lastly, although the present data demonstrate that human herpesviruses can modulate cytokine gene expression or synthesis, our results may also be pertinent to understanding the eventual contribution ofherpesviruses to both the activation ofreplication and pathogenesis of other viruses. For example, both IL-6 and TNFa are known to activate the replication of the human immunodeficiency virus (41) . Because herpesviral infections can be rampant in patients in various states ofhuman immunodeficiency virus-associated immunodeficiency, it is conceivable that herpesviruses may further contribute to the immunopathological process through cytokine induction.
In conclusion, although both EBV and HSV-l belong to the same virus family, they seem to have evolved differently in the way they interact with the immune system for inducing or inhibiting certain cytokines. The latter, likely destined initially for cell-to-cell communication, might have become molecules utilized by viruses to disrupt immune responses and favor virus survival. However, more studies are necessary to better understand the various mechanisms by which viruses modulate the immunoregulatory pathways.
